111 (NASDAQ:YI – Get Free Report) announced its quarterly earnings data on Friday, September 18th. The company reported ($0.60) earnings per share (EPS) for the quarter, Zacks reports. The firm had revenue of $338.55 million during the quarter.
111 Trading Down 2.7%
NASDAQ:YI opened at $3.22 on Friday. 111 has a 12-month low of $2.48 and a 12-month high of $11.17. The stock’s 50 day simple moving average is $3.57 and its 200-day simple moving average is $4.77. The firm has a market cap of $28.29 million, a P/E ratio of -2.01 and a beta of 0.66.
Wall Street Analyst Weigh In
Separately, Weiss Ratings upgraded 111 from a “sell (e+)” rating to a “sell (d-)” rating in a report on Monday. One investment analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, the stock has a consensus rating of “Sell”.
111 Company Profile
111, Inc is a China-based digital healthcare company that operates an online platform connecting consumers, pharmacies, hospitals, pharmaceutical manufacturers and other healthcare participants. The company focuses on improving access to medicines and healthcare products through technology-enabled distribution and retail services.
Its business includes online sales and distribution of prescription and over-the-counter medicines, medical devices, nutritional products and other healthcare merchandise.
Further Reading
- Five stocks we like better than 111
- AST SpaceMobile’s BlueBird Progress Comes With Several Risks Still Unresolved
- Time to Nibble on MCD Stock After it Enters Oversold Territory?
- McCormick Stock Trades Cheap, Offers Dividend Growth and Unilever Deal Upside
- Corning and AT&T’s $3 Billion Fiber Deal Reveals Where AI Spending Goes Next
Receive News & Ratings for 111 Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for 111 and related companies with MarketBeat.com's FREE daily email newsletter.
